Long-term Anti-VEGF Therapy for DME

Timothy Murray, MD, MBA, Charles C. Wykoff, MD, PhD

Show Description +

Charles Wykoff, MD, PhD, discusses his presentation on long-term anti-VEGF therapy for diabetic macular edema. Relying on data from VISTA study participants whose treatment extended into the fourth year after randomization, Dr. Wykoff reviews injection frequency, the effect of focal laser, and the relationship between reductions in treatment frequency and worsening of retinopathy severity.

Posted: 3/07/2017

Up Next

Name: Long-term Anti-VEGF Therapy for DME
Uploaded: 2017-03-07T09:02:00+00:00
Description: Charles Wykoff, MD, PhD, discusses his presentation on long-term anti-VEGF therapy for diabetic macular edema. Relying on data from VISTA study participants whose treatment extended into the fourth year after randomization, Dr. Wykoff reviews injection frequency, the effect of focal laser, and the relationship between reductions in treatment frequency and worsening of retinopathy severity.